Key Market Insights

• Presently, over 45 industry players claim to have the necessary capabilities to develop various organ-on-chip products and technologies, which can be used across different application areas
• Based on the intellectual property distribution across the world, RD activity related to organ-on-chip products and technologies, filed / granted by industry and non-industry players is significantly increasing in different geographical regions
• In order to support the ongoing research for organ-on-chip models, 345+ grants worth more than USD 165 million have been awarded to various companies / organizations working in this domain till July 2022
• The increased partnership activity related to organ-on-chip indicates a recent rise in the interest of players engaged in the development of organ-on-chip products and technologies
• The significant amount was invested by both private and public investors in this domain, since 2017 for the research and development of organ-on-chip products and technologies
• Case Study: Scaffold free 3D cell culture products that are developed / under development by both established and emerging players that can be used for biomedical testing
• The projected opportunity for organ-on-chip is expected to grow at the CAGR of 21.3% and segmented across different types of product, application areas, types of purpose and key geographical regions

Table of Content

1. PREFACE

1.1.                  Overview

1.2.                  Scope of the Report

1.3.                  Research Methodology

1.4.                  Key Questions Answered

1.5.                  Chapter Outlines

2. EXECUTIVE SUMMARY

3. INTRODUCTION

3.1.                  Chapter Overview

3.2.                  Background of Organ-on-Chip

3.3.                  Classification of Organ-on-Chip

3.4.                  Advantages and Limitations of Organ-on-Chip

3.5.                 Applications of Organ-on-Chip

3.6.                  Future Perspectives

4. ORGAN-ON-CHIP: MARKET LANDSCAPE

4.1.                  Chapter Overview

4.2.                  Organ-on-Chip: List of Products

4.3.                  Organ-on-Chip: Developer Landscape

5. ORGAN-ON-CHIP DEVELOPERS: COMPANY PROFILES

5.1.                  Chapter Overview

5.2.                  BEOnChip

5.2.1.               Company Overview

5.2.2.               Product Portfolio

5.2.3.               Recent Developments and Future Outlook    

5.3.                  Dynamic42

5.4.                  Emulate

5.5.                  Mimetas

5.6.                  SynVivo

5.7                   TissUse           

5.8                   uFluidix          

6. PATENT ANALYSIS

6.1.                  Chapter Overview

6.2.                  Scope and Methodology

6.3.                  Organ-on-Chip: Patent Analysis

6.4.                  Patent Benchmarking Analysis

6.5.                  Analysis by Patent Valuation

7. BRAND POSITIONING MATRIX

7.1.                  Chapter Overview

7.2                   Methodology

7.3.                  Key Parameters

7.4.                  Companies Providing Organ-on-Chip

8. ACADEMIC GRANTS ANALYSIS

8.1                   Chapter Overview

8.2.                  Scope and Methodology

8.3.                  Organ-on-Chip: Academic Grants Analysis

9. PARTNERSHIPS AND COLLABORATIONS

9.1.                  Chapter Overview

9.2.                  Partnership Models

9.3.                  Organ-on-Chip: List of Partnerships and Collaborations

10. FUNDING AND INVESTMENT ANALYSIS

10.1.                Chapter Overview

10.2.                Organ-on-Chip: List of Funding and Investments

11. CASE STUDY: SCAFFOLD-FREE 3D CELL CULTURE SYSTEMS

11.1.                Chapter Overview

11.2.                Scaffold-free Products: Market Landscape

11.3     .           Scaffold Free Products: Developer Landscape

11.4     .           Leading Developers: Analysis by Number of Scaffold Free Products

11.5     .           Tree Map Representation: Analysis by Type of Product and Company Size

12. oRGAN-ON-CHIP: MARKET FORECAST AND OPPORTUNITY ANALYSIS

12.1.                Chapter Overview

12.2.                Forecast Methodology and Key Assumptions

12.3.                Global Organ-on-Chip Market, 2022-2035

12.3.1.             Global Organ-on-Chip Market, 2022-2035: Distribution by Type of Product

12.3.2.             Global Organ-on-Chip Market, 2022-2035: Distribution by Application Area

12.3.3.             Global Organ-on-Chip Market, 2022-2035: Distribution by Purpose

12.3.4.             Global Organ-on-Chip Market, 2022-2035: Distribution by Key Geographical Regions

13. CONCLUSION

14. EXECUTIVE INSIGHTS

14.1.                Chapter Overview

14.2.                Cherry Biotech

14.2.1.             Company Snapshot

14.2.2.             Interview Transcript: Pierre Gaudriault, Chief Business Development Officer

14.3.                EDmicBio

14.4.                Hesperos

14.5.                Lena Biosciences

14.6.                react4life

14.7.                Screenin3D

15. APPENDIX 1: TABULATED DATA

16. APPENDIX 2: LIST OF COMPANIES AND ORGANIZATIONS

To view more details on this report, click on the link

https://www.rootsanalysis.com/reports/organ-on-a-chip-market.html

You may also be interested in the following titles:

About Roots Analysis

Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.

Contact:

Ben Johnson

+1 (415) 800 3415

[email protected]